Myocet ® - Carboplatine in Ovarian Cancer in Relapse, Sensitive to the Platinum - Full Text View - ClinicalTrials.gov Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Monday, October 15, 2012

Myocet ® - Carboplatine in Ovarian Cancer in Relapse, Sensitive to the Platinum - Full Text View - ClinicalTrials.gov



Myocet ® - Carboplatine in Ovarian Cancer in Relapse, Sensitive to the Platinum - Full Text View - ClinicalTrials.gov


Responsible Party: ARCAGY/ GINECO GROUP
ClinicalTrials.gov Identifier: NCT01705158     History of Changes
Other Study ID Numbers: MYCA (GINECO-OV220), 2012-001999-10
Study First Received: October 1, 2012
Last Updated: October 11, 2012
Health Authority: France: L’Agence nationale de sécurité du médicament et des produits de santé

0 comments :

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.